您的购物车当前为空
Glucocorticoid receptor modulator 4 (Compound DL5) 结合了连接子和糖皮质激素受体调节剂的特性。在 K562 细胞中,该化合物通过GRE报告机制表达mTNF,具有EC50值为40μM的活性。此外,Glucocorticoid receptor modulator 4与抗肿瘤坏死因子(TNF)抗体相结合,在小鼠模型中展现了显著的抗关节炎抗炎效应。

Glucocorticoid receptor modulator 4 (Compound DL5) 结合了连接子和糖皮质激素受体调节剂的特性。在 K562 细胞中,该化合物通过GRE报告机制表达mTNF,具有EC50值为40μM的活性。此外,Glucocorticoid receptor modulator 4与抗肿瘤坏死因子(TNF)抗体相结合,在小鼠模型中展现了显著的抗关节炎抗炎效应。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Glucocorticoid receptor modulator 4 相关产品
| 产品描述 | Compound DL5, also known as Glucocorticoid receptor modulator 4, acts as a conjugate of linkers and glucocorticoid receptor regulators. It demonstrates GRE reporter activity in K562 cells expressing mTNF with an EC50 of 40 μM. Additionally, Compound DL5 binds to anti-tumor necrosis factor (TNF) antibodies and exhibits anti-inflammatory properties in combating arthritis in mouse models. |
| 分子量 | 826.72 |
| 分子式 | C37H43BrF3N3O8S |
| CAS No. | 2688785-30-8 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容